IP Library Granted Patent US 8,128,914
Granted Patent B2
US 8,128,914 · App. 13/165,876 · Granted Mar 6, 2012

Topical compositions containing CIS-6-nonenol and its derivatives and methods for treating skin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,128,914
App. No.
13/165,876
Granted
Mar 6, 2012
Kind
B2
Abstract

Cosmetic compositions comprising cis-6-nonenol and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. Cis-6-nonenol is believed to have modulatory activity against at least one biochemical pathway implicated in skin aging.

Claims (29)

1. A method for imparting an anti-aging benefit to human skin comprising: topically applying to the skin of an individual in need thereof a composition in a cosmetically acceptable vehicle comprising an amount of cis-6-nonenol, in isolated or purified form, from 0.0001 weight % to 90 weight % based on the total weight of the composition effective to impart the anti-aging benefit to the skin.

2. The method according to claim 1 , wherein the skin suffers from skin photo-aging.

3. The method according to claim 1 , wherein said anti-aging benefit is selected from the group consisting of:

(a) treatment, reduction, and/or prevention of fine lines or wrinkles,

(b) reduction of skin pore size,

(c) improvement in skin thickness, plumpness, and/or tautness;

(d) improvement in skin suppleness and/or softness;

(e) improvement in skin tone, radiance, and/or clarity;

(f) improvement in procollagen and/or collagen production;

(g) improvement in maintenance and remodeling of elastin;

(h) improvement in skin texture and/or promotion of retexturization;

(i) improvement in skin barrier repair and/or function;

(j) improvement in appearance of skin contours;

(k) restoration of skin luster and/or brightness;

(l) replenishment of essential nutrients and/or constituents in the skin;

(m) improvement of skin appearance decreased by menopause;

(n) improvement in skin moisturization;

(o) improvement of skin elasticity and/or resiliency; or

(p) treatment, reduction, and/or prevention of skin sagging; and/or

(q) treatment, reduction, and/or prevention of discoloration of skin.

4. The method according to claim 3 , wherein said anti-aging benefit is the treatment, reduction, and/or prevention of fine lines or wrinkles.

5. The method according to claim 3 , wherein said anti-aging benefit is the treatment, reduction, and/or prevention of skin sagging.

6. The method according to claim 3 , wherein said anti-aging benefit is treatment, reduction, and/or prevention of discoloration of skin.

7. The method according to claim 3 , wherein said anti-aging benefit is improvement of skin elasticity.

8. The method according to claim 1 , wherein said cis-6-nonenol is present in an amount sufficient to enhance metallothionein activity.

9. The method according to claim 1 , wherein the cis-6-nonenol is present in an amount from 0.001 weight % to 25 weight % based on the total weight of the composition.

10. The method according to claim 9 , wherein said cis-6-nonenol is present in an amount from 0.01 weight % to 10 weight % based on the total weight of the composition.

11. A method for treating wrinkles and/or fine lines comprising: topically applying to said wrinkle and/or fine line on the skin of an individual in need thereof a composition in a cosmetically acceptable vehicle comprising an amount of cis-6-nonenol, in isolated or purified form, from 0.0001 weight % to 90 weight % based on the total weight of the composition for a time sufficient to reduce the severity of said wrinkles or fine lines.

12. A method for providing a benefit to human skin comprising: topically applying to an area of the skin damaged by UV radiation a composition in a cosmetically acceptable vehicle comprising an amount of cis-6-nonenol, in isolated or purified form, from 0.0001 weight % to 90 weight % based on the total weight of the composition for a time sufficient to improve the aesthetic appearance of the skin.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Jan 28, 2026
From: NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA &CO UK HOLDINGS LIMITED, AS A SECURED PARTY
To: AVON PRODUCTS, INC.
Reel/Frame 074508/0281 →
RELEASE OF SECURITY INTEREST Recorded Dec 11, 2024
From: NATURA &CO HOLDING S.A.; NATURA COSMETICOS S.A.; NATURA &CO LUXEMBOURG HOLDINGS S.A R.L. - LUXEMBOURG; NATURA &CO UK HOLDINGS LIMITED - UK
To: AVON PRODUCTS, INC
Reel/Frame 069591/0494 →
PATENT SECURITY AGREEMENT Recorded Aug 16, 2024
From: AVON PRODUCTS, INC.
To: NATURA &CO HOLDING S.A.; NATURA &CO LUXEMBOURG HOLDINGS S.À R.L.; NATURA COSMÉTICOS S.A.; NATURA &CO UK HOLDINGS LIMITED
Reel/Frame 068659/0915 →
SECURITY INTEREST Recorded Apr 29, 2024
From: AVON PRODUCTS, INC.; MI HOLDINGS, INC.; AVON INTERNATIONAL OPERATIONS, INC.; AVON CAPITAL CORPORATION; AVON COSMETICS LIMITED; AVON BEAUTY LIMITED
To: NATURA &CO HOLDING S.A., AS SECURED PARTY; NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA COSMÉTICOS S.A., AS A SECURED PARTY
Reel/Frame 067249/0491 →
SECURITY INTEREST Recorded Aug 11, 2023
From: AVON PRODUCTS, INC.
To: NATURA &CO LUXEMBOURG HOLDINGS S.À R.L., AS A SECURED PARTY; NATURA &CO UK HOLDINGS LIMITED, AS A SECURED PARTY
Reel/Frame 064566/0872 →
SECURITY INTEREST Recorded Nov 14, 2019
From: AVON PRODUCTS, INC.
To: CITIBANK, N.A., LONDON BRANCH
Reel/Frame 051032/0210 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Aug 15, 2016
From: CITIBANK, N.A.
To: AVON PRODUCTS, INC.
Reel/Frame 039690/0331 →
SECURITY INTEREST Recorded Jun 12, 2015
From: AVON PRODUCTS, INC.
To: CITIBANK, N.A.
Reel/Frame 035899/0776 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2011
From: PTCHELINTSEV, DMITRI S.; HWANG, CHENG SHINE
To: AVON PRODUCTS, INC.
Reel/Frame 026503/0503 →